Nutriband Inc. (NASDAQ:NTRB) Financings
Financings
| Raise | Date |
|---|---|
| Warrant exercise of warrants Closed: US$5.31M raised · Warrants at US$6.43 Use of proceeds: Remaining clinical development of AVERSA Fentanyl and submission of its NDA with the FDA for marketing approval | Sep 3, 2025 |